Addex Therapeutics Ltd (ADXN)
8.39
+0.38
(+4.75%)
USD |
NASDAQ |
May 28, 16:00
8.39
0.00 (0.00%)
After-Hours: 20:00
Addex Therapeutics Stock Buybacks (Quarterly): -1.304M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.304M |
| September 30, 2023 | -0.0229M |
| June 30, 2023 | -0.0186M |
| March 31, 2023 | -1.272M |
| December 31, 2022 | -0.4889M |
| September 30, 2022 | -1.268M |
| June 30, 2022 | -0.0093M |
| March 31, 2022 | 0.0093M |
| December 31, 2021 | -4.144M |
| September 30, 2021 | 0.0885M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0461M |
| March 31, 2021 | -11.26M |
| December 31, 2020 | -0.798M |
| September 30, 2020 | -0.0112M |
| June 30, 2020 | 0.0386M |
| March 31, 2020 | 0.0027M |
| December 31, 2019 | -0.0001M |
| September 30, 2019 | -0.0075M |
| June 30, 2019 | 0.0016M |
| March 31, 2019 | -0.0001M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-11.26M
Minimum
Mar 2021
0.0885M
Maximum
Sep 2021
-1.075M
Average
-0.0112M
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| AC Immune SA | -0.0023M |
| CRISPR Therapeutics AG | -280.74M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -- |
| MoonLake Immunotherapeutics | -52.54M |